|
|
||||||||
The Journal of Immunology, Vol 146, Issue 2 414-417, Copyright © 1991 by American Association of Immunologists
ARTICLES |
T Cotner, E Mellins, AH Johnson and D Pious
Department of Pediatrics, University of Washington, Seattle 98195.
Both exogenously derived and endogenously derived Ag generally require processing for their optimal binding and presentation by class I and class II major histocompatibility proteins. It is not known whether steps involved in Ag processing also affect the recognition of alloreactive T cells. We have recently described B cell mutants which have general defects in the processing and presentation of a variety of exogenous Ag to class II restricted T cells. In this report we have studied the ability of these processing mutants to stimulate a set of anti-DR3-specific alloreactive T cells clones. These processing/presentation mutants express normal MHC class II molecules, both in terms of primary sequence and cell surface abundance, but they appear unable to generate effective peptide-MHC complexes. When tested for their ability to stimulate MHC class II alloreactive T cell clones, only one of four T cell clones was stimulated by these mutants; the other three alloreactive T cell clones were not stimulated by either of two different mutants. Both of these mutants express normal levels of the accessory molecules, LFA-3 and ICAM-1. The inability of these mutants to stimulate three of four alloreactive clones indicates that the capacity to be recognized by many alloreactive T cells is linked to the Ag processing capacity of a stimulator cell.
This article has been cited by other articles:
![]() |
M. Peterson and A. J. Sant The Inability of the Nonobese Diabetic Class II Molecule to Form Stable Peptide Complexes Does Not Reflect a Failure to Interact Productively with DM J. Immunol., September 15, 1998; 161(6): 2961 - 2967. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Grigg, C. W. McMahon, S. Morkowski, A. Y. Rudensky, and A. M. Pullen Mtv-1 Superantigen Trafficks Independently of Major Histocompatibility Complex Class II Directly to the B-Cell Surface by the Exocytic Pathway J. Virol., April 1, 1998; 72(4): 2577 - 2588. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Daniel, A. Grakoui, and P. M. Allen Inhibition of an In Vitro CD4+ T Cell Alloresponse Using Altered Peptide Ligands J. Immunol., April 1, 1998; 160(7): 3244 - 3250. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Sette, S Ceman, R. Kubo, K Sakaguchi, E Appella, D. Hunt, T. Davis, H Michel, J Shabanowitz, R Rudersdorf, et al. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant Science, December 11, 1992; 258(5089): 1801 - 1804. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |